Argentum Falters Again On Gilenya As US Supreme Court Says No

Federal Circuit Told Argentum It Lacked Standing To Appeal

 
• By Dean Rudge
  
US-Supreme-Court_V2_1200
Argentum had argued that joint ventures "have become the norm and indeed part of the very fabric of the pharma industry." • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Legal & IP

More from Generics Bulletin